scispace - formally typeset
G

Gerardo Turcatti

Researcher at École Polytechnique Fédérale de Lausanne

Publications -  90
Citations -  8491

Gerardo Turcatti is an academic researcher from École Polytechnique Fédérale de Lausanne. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 30, co-authored 80 publications receiving 7649 citations. Previous affiliations of Gerardo Turcatti include École Polytechnique & Illumina.

Papers
More filters
Journal ArticleDOI

Accurate whole human genome sequencing using reversible terminator chemistry

David R. Bentley, +201 more
- 06 Nov 2008 - 
TL;DR: An approach that generates several billion bases of accurate nucleotide sequence per experiment at low cost is reported, effective for accurate, rapid and economical whole-genome re-sequencing and many other biomedical applications.
Journal ArticleDOI

Solid phase DNA amplification: characterisation of primer attachment and amplification mechanisms

TL;DR: These new surface amplification processes are seen as an interesting approach for attachment of DNA molecules by their 5'-end on a solid support and can be used as an alternative route for producing DNA chips for genomic studies.
Patent

Methods of nucleic acid amplification and sequencing

TL;DR: In this article, the authors propose a method for the amplification and sequencing of at least one nucleic acid comprising the following steps: (1) forming at least a template comprising the nucleic acids to be amplified or sequenced; (2) mixing the template(s) with one or more colony primers X, which can hybridize to the oligonucleotide sequence Z and carries at the 5′ end a means for attaching the primers to a solid support, in the presence of a solid supports so that the 5' ends of both the nuclei acid template
Journal ArticleDOI

Targeting STING with covalent small-molecule inhibitors

TL;DR: The discovery and characterization of small-molecule antagonists that inhibit the stimulator of interferon genes (STING) protein may help to develop therapies for the treatment of autoinflammatory disease.